Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium chloride nasal spray versus placebo in children with allergic rhinitis
IRCT20150426021944N6Phase 4Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Sep 2025
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sodium chloride in allergic rhinitis (AR) and asthma (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Total Nasal Symptom Score change, Rhinoconjunctivitis Quality of Life Questionnaire change and 2 more. Started Sep 2025; status: completed.
02
Drugs
sodium chloride
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on IRCT20150426021944N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150426021944N6.